Managers / Q2 2025 · view latest →
Riverview Capital Advisers, LLC
CIK 0001962933 · 265 FRANKLIN STREET, SUITE 400, BOSTON, MA, 02110 · 617-423-0080
Summary
Riverview Capital Advisers, LLC reported $349M in U.S.-listed holdings across 97 positions for Q2 2025.
Its largest position, BRK/B, represents 7.3% of the portfolio.
Compared with Q1 2025, the fund opened 11 new positions and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 59.6% · $208M
- ETP · 26.3% · $92M
- REIT · 12.4% · $43M
- ADR · 1.5% · $5M
- NY Reg Shrs · 0.2% · $592,738
- Other · 0.1% · $236,756
Quarter-over-Quarter Changes full breakdown →
vs Q1 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| URIUNITED RENTALS INC | NEW | +7.2K | 7.2K | +$5M | $5M |
| RRYDER SYS INC | NEW | +29.1K | 29.1K | +$5M | $5M |
| TOLTOLL BROTHERS INC | NEW | +24.4K | 24.4K | +$3M | $3M |
| MTHMERITAGE HOMES CORP | NEW | +23.2K | 23.2K | +$2M | $2M |
| ORCLORACLE CORP | NEW | +1.4K | 1.4K | +$301,458 | $301,458 |
| FIRST TR EXCHANGE TRADED FD | NEW | +2.7K | 2.7K | +$201,690 | $201,690 |
| CLRBCELLECTAR BIOSCIENCES INC | NEW | +10.5K | 10.5K | +$74,655 | $74,655 |
| SERASERA PROGNOSTICS INC | NEW | +12.7K | 12.7K | +$35,271 | $35,271 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $300M | 86 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $330M | 91 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $346M | 98 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $349M | 97 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $318M | 88 | May 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $331M | 91 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $325M | 83 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $297M | 83 | Aug 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $290M | 80 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $261M | 79 | Feb 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $226M | 79 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $228M | 78 | Aug 4, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $232M | 80 | May 3, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $186M | 73 | Feb 8, 2023 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.